======= AKR1C3 ======= == Gene Information == * **Official Symbol**: AKR1C3 * **Official Name**: aldo-keto reductase family 1 member C3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8644|8644]] * **UniProt**: [[https://www.uniprot.org/uniprot/P42330|P42330]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AKR1C3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AKR1C3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603966|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]. * **UniProt Summary**: N/A |Aldo ket red| |ketoreductase activity| |15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity| |prostaglandin D2 11-ketoreductase activity| |negative regulation of isoprenoid metabolic process| |negative regulation of retinoic acid biosynthetic process| |prostaglandin H2 endoperoxidase reductase activity| |prostaglandin-F synthase activity| |dihydrotestosterone 17-beta-dehydrogenase activity| |farnesol metabolic process| |sesquiterpenoid metabolic process| |delta4-3-oxosteroid 5beta-reductase activity| |geranylgeranyl reductase activity| |regulation of retinoic acid biosynthetic process| |farnesol catabolic process| |sesquiterpenoid catabolic process| |phenanthrene 9,10-monooxygenase activity| |polyprenol catabolic process| |regulation of testosterone biosynthetic process| |indanol dehydrogenase activity| |regulation of isoprenoid metabolic process| |cellular response to jasmonic acid stimulus| |trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity| |testosterone 17-beta-dehydrogenase (NADP+) activity| |response to jasmonic acid| |testosterone dehydrogenase (NAD+) activity| |response to prostaglandin D| |testosterone biosynthetic process| |androsterone dehydrogenase activity| |cellular response to prostaglandin D stimulus| |ketosteroid monooxygenase activity| |negative regulation of vitamin metabolic process| |terpenoid catabolic process| |polyprenol metabolic process| |oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor| |retinal dehydrogenase activity| |polyketide metabolic process| |daunorubicin metabolic process| |doxorubicin metabolic process| |isoprenoid catabolic process| |aminoglycoside antibiotic metabolic process| |steroid dehydrogenase activity| |aldo-keto reductase (NADP) activity| |cyclooxygenase pathway| |negative regulation of hormone metabolic process| |NADP-retinol dehydrogenase activity| |progesterone metabolic process| |alcohol dehydrogenase (NADP+) activity| |regulation of vitamin metabolic process| |alditol:NADP+ 1-oxidoreductase activity| |tertiary alcohol metabolic process| |renal absorption| |retinal metabolic process| |primary alcohol catabolic process| |regulation of ketone biosynthetic process| |regulation of retinoic acid receptor signaling pathway| |prostanoid biosynthetic process| |positive regulation of endothelial cell apoptotic process| |prostaglandin biosynthetic process| |retinol dehydrogenase activity| |glycoside metabolic process| |cellular response to prostaglandin stimulus| |regulation of hormone biosynthetic process| |ketone biosynthetic process| |C21-steroid hormone metabolic process| |response to prostaglandin| |quinone metabolic process| |positive regulation of epithelial cell apoptotic process| |prostanoid metabolic process| |prostaglandin metabolic process| |cellular response to cadmium ion| |regulation of hormone metabolic process| |retinol metabolic process| |unsaturated fatty acid biosynthetic process| |icosanoid biosynthetic process| |steroid hormone biosynthetic process| |negative regulation of lipid biosynthetic process| |regulation of endothelial cell apoptotic process| |antibiotic catabolic process| |cellular aldehyde metabolic process| |cellular response to fatty acid| |secondary metabolic process| |alcohol catabolic process| |arachidonic acid metabolic process| |cellular response to corticosteroid stimulus| |hormone biosynthetic process| |response to cadmium ion| |cellular ketone metabolic process| |organic hydroxy compound catabolic process| |primary alcohol metabolic process| |regulation of epithelial cell apoptotic process| |negative regulation of lipid metabolic process| |cellular response to calcium ion| |cellular response to alcohol| |response to fatty acid| |regulation of steroid biosynthetic process| |intracellular| |negative regulation of small molecule metabolic process| |cellular response to ketone| |fatty acid derivative biosynthetic process| |positive regulation of reactive oxygen species metabolic process| |retinoid metabolic process| |antibiotic metabolic process| |unsaturated fatty acid metabolic process| |diterpenoid metabolic process| |renal system process| |icosanoid metabolic process| |regulation of steroid metabolic process| |long-chain fatty acid metabolic process| |oxidoreductase activity| |fatty acid biosynthetic process| |terpenoid metabolic process| |cellular hormone metabolic process| |steroid biosynthetic process| |cellular response to reactive oxygen species| |male gonad development| |glycosyl compound metabolic process| |development of primary male sexual characteristics| |isoprenoid metabolic process| |response to calcium ion| |cellular response to starvation| |male sex differentiation| |response to corticosteroid| |positive regulation of protein kinase B signaling| |fatty acid derivative metabolic process| |regulation of cellular ketone metabolic process| |regulation of reactive oxygen species metabolic process| |monocarboxylic acid biosynthetic process| |organic hydroxy compound biosynthetic process| |regulation of lipid biosynthetic process| |cellular response to steroid hormone stimulus| |cellular response to metal ion| |response to starvation| |response to ketone| |ammonium ion metabolic process| |response to reactive oxygen species| |cellular lipid catabolic process| |hormone metabolic process| |cellular response to acid chemical| |gonad development| |response to nutrient| |development of primary sexual characteristics| |cellular response to inorganic substance| |regulation of protein kinase B signaling| |response to alcohol| |cellular response to nutrient levels| |cellular response to oxidative stress| |steroid metabolic process| |cellular response to extracellular stimulus| |sex differentiation| |keratinocyte differentiation| |lipid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |epidermal cell differentiation| |alcohol metabolic process| |fatty acid metabolic process| |response to steroid hormone| |cellular response to external stimulus| |response to acid chemical| |response to metal ion| |skin development| |response to oxidative stress| |regulation of lipid metabolic process| |epidermis development| |reproductive structure development| |regulation of small molecule metabolic process| |reproductive system development| |small molecule catabolic process| |cofactor metabolic process| |organic hydroxy compound metabolic process| |response to nutrient levels| |drug metabolic process| |cellular response to lipid| |monocarboxylic acid metabolic process| |response to extracellular stimulus| |regulation of hormone levels| |response to inorganic substance| |cellular response to organic cyclic compound| |lipid biosynthetic process| |small molecule biosynthetic process| |cellular response to hormone stimulus| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |developmental process involved in reproduction| |epithelial cell differentiation| |positive regulation of cell death| |response to lipid| |response to hormone| |carboxylic acid metabolic process| |positive regulation of cell population proliferation| |response to organic cyclic compound| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |positive regulation of intracellular signal transduction| |organic acid metabolic process| |carbohydrate derivative metabolic process| |cellular response to oxygen-containing compound| |epithelium development| |lipid metabolic process| |cellular response to endogenous stimulus| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |reproductive process| |reproduction| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of signal transduction| |regulation of cell death| |cellular response to stress| |small molecule metabolic process| |tissue development| |organic substance catabolic process| |cellular catabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |system process| \\ === CRISPR Data === No hits were found. ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.41| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12351 * **Expression level (log2 read counts)**: -0.75 {{:chemogenomics:nalm6 dist.png?nolink |}}